Standard Biotools | FLDM - Gross Profit On Sales


Standard Biotools reported $9.48M in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
Agilent USD 946M 44M Dec/2025
Becton, Dickinson and Co. USD 2.41B 1.72B Dec/2025
Bio-Rad Laboratories USD 343.4M 1.9M Sep/2025
Bruker USD 449.2M 69.8M Dec/2025
Danaher USD 3.97B 443M Dec/2025
Illumina USD 759M 26M Dec/2025
Myriad Genetics USD 143.8M 8M Sep/2025
Nikon Corporation JPY 67.21B 14.78B Jun/2025
Pacific Biosciences Of California USD 10M 4.07M Sep/2024
Revvity USD 421.66M 47.06M Dec/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
Sony JPY 1.01T 160.99B Sep/2025
Standard Biotools USD 9.48M 1.15M Sep/2025
Thermo Fisher Scientific USD 4.64B 419M Dec/2025
Waters USD 557.42M 97.44M Dec/2025